Company: G
Filing Date: 2025-04-09
Form Type: DEF 14A
Source: 0001140361-25-013031
Chunk: 84

Company: Genpact LTD
Filing Date: 2025-04-09
Form: DEF 14A
Chunk 84
---
 exercise price does not take into account RSUs, PSUs, or purchase rights under the Company’s Employee Stock Purchase Plans. |

| (3) | The amounts in this column are comprised of (i) 1,204,753 shares reserved for issuance under the Company’s Employee Stock Purchase Plans and (ii) 8,873,846 shares available for issuance under the Company’s 2017 Omnibus Incentive Compensation Plan. |

Compensation committee interlocks and insider participation During fiscal 2024, Mmes. Franklin, Lindstrom and Morken and Mr. Madden served as members of our compensation committee. No member of our compensation committee was at any time during fiscal 2024, or formerly, an officer or employee of Genpact Limited or any subsidiary of Genpact Limited. No member of our compensation committee had any relationship with us during fiscal 2024 requiring disclosure under Item 404 of Regulation S-K under the Securities Act of 1933. During fiscal 2024, none of our executive officers served as a member of the board of directors or compensation committee (or other committee serving an equivalent function) of any entity that had one or more executive officers serving as a member of our board of directors or compensation committee. Compensation committee report The compensation committee has reviewed and discussed the Compensation discussion and analysis required by Item 402(b) of Regulation S-K with the Company’s management. Based on its review and such discussions, the compensation committee recommended to the Company’s board of directors that the Compensation discussion and analysis be included in this proxy statement. By the compensation committee of the board of directors of Genpact Limited. Carol Lindstrom, Chair Tamara Franklin James Madden CeCelia Morken

| 66 | 2025 Proxy Statement |

TABLE OF CONTENTS

| Board                                                                                                                                                                                                                                
 recommendation                                                                                                                                                                                                                       
 The board recommends that you vote“FOR”the approval, on a non-binding, advisory basis, of the compensation of our named executive officers as disclosed in this proxy statement pursuant to the SEC’s compensation disclosure rules. |

Proposal No. 2 — Non-binding vote on executive compensation The Company’s shareholders are entitled to vote at the annual general meeting to approve, on an advisory, non-binding basis, the compensation of our named executive officers, as disclosed in this proxy statement in accordance with the standards established under Item 402 of Regulation S-K under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The shareholder vote on executive compensation is an advisory vote only,